Home > Education Hub > Alira Health and Biocat Announce Startup Support Program for 2024

Alira Health and Biocat Announce Startup Support Program for 2024

Following the success of the 2023 program, Alira Health, a global healthcare advisory and technology company, and Biocat, strategic stakeholder and catalyst for promoting, transforming, and projecting the Catalan life sciences and health innovation ecosystem, are pleased to announce the Startup Support Program for 2024.

News

Category:

Market Access Startups

Published on:

January 18, 2024

The Startup Support Program 2024 assists selected startup companies in evaluating product maturity and creating a roadmap for market access. The program offers:

Guidance from an experienced team of Alira Health market access consultants to enhance companies’ value propositions, help them navigate the ecosystem, and define their needs.
A complimentary 40-hour service package covering a kick-off meeting, background analysis, reimbursement request orientation sessions, identification of key activities, and additional consultations.

This year’s edition is open for startups based in Catalonia and focused on Advanced Therapy Medicinal Products.

“Advanced Therapies represent a groundbreaking opportunity to address unmet patient needs. We are excited to offer our market expertise to support startups in the development of these cutting-edge therapies."

Chus Castillo Partner Consulting Iberia, Alira Health

“Biocat is committed to boosting the Advanced Therapies sector in Catalonia, and one example of this commitment is the Hub for Advanced and Emerging Therapies in Catalonia, which we coordinate. The Startup Support Program 2024 with Alira Health will help boost the development of this sector,” said Núria Martí, Director of Innovation and Business Development at Biocat.